These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8971788)

  • 1. Identification of advanced glycation end products of the Maillard reaction in Pick's disease.
    Kimura T; Ikeda K; Takamatsu J; Miyata T; Sobue G; Miyakawa T; Horiuchi S
    Neurosci Lett; 1996 Nov; 219(2):95-8. PubMed ID: 8971788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
    Kimura T; Takamatsu J; Miyata T; Miyakawa T; Horiuchi S
    Pathol Int; 1998 Aug; 48(8):575-9. PubMed ID: 9736403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of clathrin light chains in the pathology of Pick's disease; implication for impairment of axonal transport.
    Nakamura Y; Takeda M; Yoshimi K; Hattori H; Hariguchi S; Hashimoto S; Nishimura T
    Neurosci Lett; 1994 Oct; 180(1):25-8. PubMed ID: 7533277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
    Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain.
    Jono T; Kimura T; Takamatsu J; Nagai R; Miyazaki K; Yuzuriha T; Kitamura T; Horiuchi S
    Pathol Int; 2002 Sep; 52(9):563-71. PubMed ID: 12406185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons.
    Kimura T; Takamatsu J; Ikeda K; Kondo A; Miyakawa T; Horiuchi S
    Neurosci Lett; 1996 Apr; 208(1):53-6. PubMed ID: 8731173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
    Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical and ultrastructural studies of Pick's disease.
    Murayama S; Mori H; Ihara Y; Tomonaga M
    Ann Neurol; 1990 Apr; 27(4):394-405. PubMed ID: 2162145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filaments of Pick's bodies contain altered cytoskeletal elements.
    Perry G; Stewart D; Friedman R; Manetto V; Autilio-Gambetti L; Gambetti P
    Am J Pathol; 1987 Jun; 127(3):559-68. PubMed ID: 3296772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
    Muntané G; Dalfó E; Martínez A; Rey MJ; Avila J; Pérez M; Portero M; Pamplona R; Ayala V; Ferrer I
    J Neurochem; 2006 Oct; 99(1):177-85. PubMed ID: 16987245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pick's disease. A special type of pathological aging of the brain].
    Seitelberger F
    Aktuelle Gerontol; 1982 Nov; 12(6):200-5. PubMed ID: 6130712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
    Litvan I; Agid Y; Sastry N; Jankovic J; Wenning GK; Goetz CG; Verny M; Brandel JP; Jellinger K; Chaudhuri KR; McKee A; Lai EC; Pearce RK; Bartko JJ
    Neurology; 1997 Jul; 49(1):62-9. PubMed ID: 9222171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobar atrophy without Pick bodies.
    Hulette CM; Crain BJ
    Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end-products in diabetic nephropathy.
    Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
    Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
    J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Maillard reaction and food allergies: is there a link?
    Toda M; Heilmann M; Ilchmann A; Vieths S
    Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Pick's disease with unusual neuronal inclusions.
    Yokoo H; Oyama T; Hirato J; Sasaki A; Nakazato Y
    Acta Neuropathol; 1994; 88(3):267-72. PubMed ID: 7528965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
    Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
    Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.